tetano
Editor, Senior Moderator
Prenat Diagn
. 2020 May 26.
doi: 10.1002/pd.5759. Online ahead of print.
Sars-CoV-2 in the Context of Past Coronaviruses Epidemics: Consideration for Prenatal Care
Valentine Lambelet[SUP] 1 [/SUP], Manon Vouga[SUP] 1 [/SUP], L?o Pomar[SUP] 1 [/SUP], Guillaume Favre[SUP] 1 [/SUP], Eva Gerbier[SUP] 1 2 3 [/SUP], Alice Panchaud[SUP] 2 3 4 [/SUP], David Baud[SUP] 1 [/SUP]
Affiliations
Abstract
Since December 2019, the novel SARS-CoV-2 outbreak has resulted in millions of cases and more than 200,000 deaths worldwide. The clinical course among non-pregnant women has been described but data about potential risks for women and their fetus remain scarce. The SARS and MERS epidemics were responsible for miscarriages, adverse fetal and neonatal outcomes and maternal deaths. For COVID-19 infection, only 9 cases of maternal death have been reported as of April 22, 2020 and pregnant women seem to develop the same clinical presentation as the general population. However, severe maternal cases, as well as prematurity, fetal distress and stillbirth among newborns have been reported. The SARS-CoV-2 pandemic greatly impacts prenatal management and surveillance and raise the need for clear unanimous guidelines. In this narrative review, we describe the current knowledge about coronaviruses (SARS, MERS and SARS-CoV-2) risks and consequences on pregnancies and we summarize available current candidate therapeutic options for pregnant women. Finally, we compare current guidance proposed by RCOG, ACOG and the WHO to give an overview of prenatal management which should be utilized until future data appear. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
. 2020 May 26.
doi: 10.1002/pd.5759. Online ahead of print.
Sars-CoV-2 in the Context of Past Coronaviruses Epidemics: Consideration for Prenatal Care
Valentine Lambelet[SUP] 1 [/SUP], Manon Vouga[SUP] 1 [/SUP], L?o Pomar[SUP] 1 [/SUP], Guillaume Favre[SUP] 1 [/SUP], Eva Gerbier[SUP] 1 2 3 [/SUP], Alice Panchaud[SUP] 2 3 4 [/SUP], David Baud[SUP] 1 [/SUP]
Affiliations
- PMID: 32453451
- DOI: 10.1002/pd.5759
Abstract
Since December 2019, the novel SARS-CoV-2 outbreak has resulted in millions of cases and more than 200,000 deaths worldwide. The clinical course among non-pregnant women has been described but data about potential risks for women and their fetus remain scarce. The SARS and MERS epidemics were responsible for miscarriages, adverse fetal and neonatal outcomes and maternal deaths. For COVID-19 infection, only 9 cases of maternal death have been reported as of April 22, 2020 and pregnant women seem to develop the same clinical presentation as the general population. However, severe maternal cases, as well as prematurity, fetal distress and stillbirth among newborns have been reported. The SARS-CoV-2 pandemic greatly impacts prenatal management and surveillance and raise the need for clear unanimous guidelines. In this narrative review, we describe the current knowledge about coronaviruses (SARS, MERS and SARS-CoV-2) risks and consequences on pregnancies and we summarize available current candidate therapeutic options for pregnant women. Finally, we compare current guidance proposed by RCOG, ACOG and the WHO to give an overview of prenatal management which should be utilized until future data appear. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.